We also observed that hepatic expression of autophagy components, ATG7, ULK1, and LC3-II, as well as autophagy gene activators, JMJD3 and TFEB, and p-ERK levels are decreased in NAFLD patients. Here, ATG7 is linked to metabolic dysfunction-associated steatotic liver disease.